Genetic Disorders Causing Tissue Mineralization Abnormalities

Displaying 1 - 4 of 4CSV
Korytnikova, E., & Halasz, C. L. (2025). Chronic nonscarring scalp folliculitis responding to topical phosphodiesterase-4 inhibitor roflumilast. JAAD Case Reports, 55, 94–96. https://doi.org/10.1016/j.jdcr.2024.11.009
Publication Date
Folkvaljon, F., Gertz, M., Gillmore, J. D., Khella, S., Masri, A., Maurer, M. S., Cruz, M. W., Wixner, J., Chen, J., Reicher, B., Kwoh, J., Yarlas, A., & Berk, J. L. (2024). Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health‐Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis. Muscle & Nerve, 71(1), 96–107. Portico. https://doi.org/10.1002/mus.28299
Publication Date
Gertz, M., Abonour, R., Gibbs, S., Finkel, M., Landau, H., Lentzsch, S., Lin, G., Mahindra, A., Quock, T., Rosenbaum, C., Rosenzweig, M., Sidana, S., Tuchman, S., Witteles, R., Yermilov, I., & Broder, M. (2023). Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis. ClinicoEconomics and Outcomes Research, Volume 15, 673–680. https://doi.org/10.2147/ceor.s412079
Publication Date